Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...
Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...
Complete Invesco Nasdaq Free Cash Flow Achievers ETF funds overview by Barron's. View the QOWZ funds market news ...
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from ...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue ...
DXCM's expanding CGM reach, G7 15 Day rollout and international momentum support growth, but can reimbursement and cost risks ...
StockStory.org on MSN
Patient monitoring stocks Q1 results: Benchmarking DexCom (NASDAQ:DXCM)
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...
Mark Andrews may be one of the best tight ends in the NFL, but he has not forgotten about the kids playing college football today. The former Oklahoma Sooners standout is using his platform as an ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
FAI among sports organisations criticised over delays, with Minister saying projects cannot continue on the ‘never-never’ ...
Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results